Also trades as: 0HKF.L (LSE) · $vol 0M
AXSM NASDAQ
Axsome Therapeutics, Inc.
1W: -8.1%
1M: -14.6%
3M: -26.1%
YTD: +0.3%
1Y: +51.2%
3Y: +148.0%
5Y: +436.7%
$179.25
-2.82 (-1.55%)
Weekly Expected Move ±5.7%
$159
$169
$179
$189
$200
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships6
As Filer
counterparties named
1
As Counterparty
mentioned by others
4
Rel. Types
2022-03-28
Earliest Filing
2025-11-12
Latest Filing
licensee: 2
partner: 2
supplier: 1
target: 1
Counterparties (Filed by AXSM)
6 relationshipsCompanies named in AXSM's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Atnahs Pharma UK Limited | — | licensee | Exclusive licensee for the development and commercialization of Sunosi in Europe and MENA. | 2023-02-22 | View |
| Pharmanovia | — | licensee | Global lifecycle management healthcare company acting as the licensee for Sunosi in Europe and MENA. | 2023-02-22 | View |
| Jazz Pharmaceuticals plc | JAZZ | supplier | Axsome Therapeutics acquired worldwide rights to Sunosi (excluding twelve Asian markets) from Jazz Pharmaceuticals. | 2022-11-14 | View |
| Jazz Pharmaceuticals plc | JAZZ | target | Seller of Sunosi assets to Axsome Therapeutics | 2022-03-28 | View |
| SK Biopharmaceuticals | — | partner | Originator of Sunosi retaining rights in Asian markets | 2022-03-28 | View |
| Aerial Biopharma | — | partner | Original rights holder of Sunosi prior to Jazz acquisition | 2022-03-28 | View |
Mentioned As Counterparty
1 mentionsOther companies that named AXSM in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-10 | Earnings Release; Other Events; Exhibits | View | |
| 2026-07-15 | Other Events; Exhibits | View | |
| 2026-06-09 | Officer/Director Change; Exhibits | View | |
| 2026-06-09 | Shareholder Vote; Exhibits | View | |
| 2026-06-03 | Other Events; Exhibits | View | |
| 2026-05-04 | Earnings Release; Other Events; Exhibits | View | |
| 2026-04-30 | Other Events; Exhibits | View | |
| 2026-04-01 | Other Events; Exhibits | View | |
| 2026-02-23 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-17 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-12-31 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-03 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-20 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-04 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-10 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-09 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-09 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-05-27 | Other Events; Financial Statements and Exhibits | View | |
| 2025-05-13 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR